NATIONAL HEREDITARY BREAST CANCER HELPLINEActive

Company number 07877025Private company limited by guaranteeIncorporated 2011

Key figures

£38,905-61.5%
Net assets 2024/25
-8.0%
Average annual change 2019/20–2024/25
050 k100 k150 k2019/202020/212021/222023/242024/25

Like most small UK companies, NATIONAL HEREDITARY BREAST CANCER HELPLINE does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k300 k2019/202020/212021/222023/242024/25
Filed accounts2019/20–2024/25
2019/202020/212021/222023/242024/25
Cash at bank and in hand1,89859,06221,4974,6782,194
Total assets157,380216,134163,976175,67289,293
Total liabilities216,437131,46275,29490,182136,218
Net assets / total equity54,312102,994120,472100,97338,905
Average number of employees1813161411

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: NATIONAL HEREDITARY BREAST CANCER HELPLINE

Company

NATIONAL HEREDITARY BREAST CANCER HELPLINE is a private company limited by guarantee registered with Companies House under company number 07877025. It was incorporated on 9 Dec 2011. Its status is active. The registered office is in Chesterfield (S41). Its nature of business (SIC 2007) is retail sale of other second-hand goods in stores (not incl. antiques) (47799), other human health activities (86900).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Net assets were £38,905, down 61.5% on the previous year. Cash at bank and in hand was £2,194. Total assets were £89,293 and total liabilities £136,218. The company had an average of 11 employees. Figures are available for 5 financial years (2019/20–2024/25).

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 23 Dec 2026.